Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion type Assertion NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_head.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion description "[Gene mutations of KIT or PDGFRA are critical in GISTs, because the aberrant versions not only are correlated with the specific cell morphology, histologic phenotype, metastasis, and prognosis, but also are the targets of therapy with imatinib and other agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_provenance.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion evidence source_evidence_literature NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_provenance.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion SIO_000772 18671247 NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_provenance.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion wasDerivedFrom befree-2016 NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_provenance.
- NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_assertion wasGeneratedBy ECO_0000203 NP685409.RAXz5BVVUnoyw92KJHruYtPL6_FvUwlUgaXIKSQQ3TAjI130_provenance.